A study of the intrinsic molecular classes of HER2 + BC revealed that BC assigned to the HER2-E subtype by RNA-seq analysis is more likely to achieve a pCR compared to other intrinsic subtypes [17]. The gene discussed is ERBB2; the disease is breast cancer.